![Jay Moyes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Moyes
Directeur/Membre du Conseil chez
BIOCARDIA, INC.
Fortune : 430 492 $ au 31/05/2026
Profil
Mr. Jay M.
Moyes is an Independent Director at SINTX Technologies, Inc., a Lead Independent Director at Puma Biotechnology, Inc., an Independent Director at BioCardia, Inc., a Managing Member at Drayton Investments LLC and a Member at Utah Association of Certified Public Accountants.
He is on the Board of Directors at SINTX Technologies, Inc., Puma Biotechnology, Inc. and BioCardia, Inc. Mr. Moyes was previously employed as a Chief Financial Officer & Treasurer by Sera Prognostics, Inc., an Independent Director by Predictive Technology Group, Inc., an Independent Director by Achieve Life Sciences, Inc., an Independent Director by Integrated Diagnostics, Inc., a Chief Financial Officer by XDx, Inc., an Independent Non-Executive Director by Osiris Therapeutics, Inc., a Trustee by Utah Life Science Association, a Chief Financial Officer by Myriad Genetics, Inc., a Chief Financial Officer & Vice President-Finance by Genmarks, Inc., and a Senior Manager by KPMG LLP.
He also served on the board at BioCardia, Inc. /Old/.
He received his undergraduate degree from Weber State University and an MBA from the University of Utah.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC. 0,11 % | 12/06/2026 | 58 322 ( 0,11 % ) | 418 169 $ | 31/05/2026 |
SINTX TECHNOLOGIES, INC. 0,09 % | 23/02/2026 | 4 000 ( 0,09 % ) | 8 960 $ | 31/05/2026 |
BIOCARDIA, INC. 0,03 % | 08/12/2025 | 3 616 ( 0,03 % ) | 3 363 $ | 31/05/2026 |
Postes actifs de Jay Moyes
| Sociétés | Poste | Début |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 27/04/2012 |
| BIOCARDIA, INC. | Directeur/Membre du Conseil | 01/01/2011 |
| SINTX TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 03/04/2025 |
Drayton Investments LLC | Corporate Officer/Principal | - |
Utah Association of Certified Public Accountants | Corporate Officer/Principal | 03/06/2010 |
Anciens postes connus de Jay Moyes
| Sociétés | Poste | Fin |
|---|---|---|
| SERA PROGNOSTICS, INC. | Directeur Financier/CFO | 07/06/2023 |
| ACHIEVE LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 07/06/2023 |
| PREDICTIVE TECHNOLOGY GROUP, INC. | Directeur/Membre du Conseil | 01/12/2019 |
| OSIRIS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 13/12/2017 |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Jay Moyes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues | Health Technology |
Genmarks, Inc.
 Genmarks, Inc. Engineering & ConstructionIndustrial Services Part of Nutrien Ltd., Genmarks, Inc. is a company based in Greeley, CO. | Industrial Services |
CareDx, Inc.
 CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
SINTX Technologies, Inc.
 SINTX Technologies, Inc. Medical SpecialtiesHealth Technology Develops and designs spinal & reconstructive orthopedic devices | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Integrated Diagnostics, Inc.
 Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a molecular diagnostics company | Health Services |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weber State University
 Weber State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Utah Life Science Association
 Utah Life Science Association Miscellaneous Commercial ServicesCommercial Services Develops partnerships in the life science industries | Commercial Services |
Utah Association of Certified Public Accountants | |
BioCardia, Inc. /Old/
 BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Health Technology |
Predictive Technology Group, Inc.
 Predictive Technology Group, Inc. Medical SpecialtiesHealth Technology Develops technologies involved in novel molecular diagnostic and therapeutic products in healthcare | Health Technology |
Sera Prognostics, Inc.
 Sera Prognostics, Inc. Medical/Nursing ServicesHealth Services Provides personalized diagnostics to predict and manage pregnancy complications | Health Services |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
Drayton Investments LLC | |
BioCardia, Inc.
 BioCardia, Inc. BiotechnologyHealth Technology Develops biotherapeutics for cardiovascular disease | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
